Cargando…
Safety and efficacy of polymyxin B in multidrug resistant Gram-negative severe sepsis and septic shock
BACKGROUND AND AIMS: The emergence of multidrug resistant strains of Gram-negative bacteria, especially the lactose nonfermenters like Pseudomonas and Acinetobacter, in the intensive care units have prompted renewed worldwide interest in the polymyxins. However, perceived nephrotoxicity has been a m...
Autores principales: | Ramasubban, Suresh, Majumdar, Ayanava, Das, Purnendu Sekhar |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2738329/ https://www.ncbi.nlm.nih.gov/pubmed/19742270 http://dx.doi.org/10.4103/0972-5229.45074 |
Ejemplares similares
-
Efficacy of polymyxin B-immobilized fiber hemoperfusion for patients with septic shock caused by Gram-negative bacillus infection
por: Saito, Nobuyuki, et al.
Publicado: (2017) -
Antimicrobial Peptides for Gram-Negative Sepsis: A Case for the Polymyxins
por: David, Sunil A.
Publicado: (2012) -
Low-dose polymyxin: an option for therapy of Gram-negative sepsis
por: Harm, Stephan, et al.
Publicado: (2016) -
The clinical impact of multidrug-resistant gram-negative bacilli in the management of septic shock
por: Pop-Vicas, Aurora, et al.
Publicado: (2014) -
Efficacy and safety of polymyxin B in carbapenem-resistant gram-negative organisms infections
por: Xia, G. L., et al.
Publicado: (2021)